Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tariquidar + Vinorelbine in Stage IIIb/IV NSCLC
NCT00042315Phase 3Terminated
- Sponsor
- QLT Inc.
- Start
- Jun 2002
- Primary completion
- Jun 2003
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of tariquidar in non-small cell lung cancer (NSCLC), sponsored by QLT Inc.. Started Jun 2002; status: terminated.
02
Drugs
tariquidar
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00042315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00042315.